These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20801542)

  • 1. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial.
    Moreno C; Langlet P; Hittelet A; Lasser L; Degré D; Evrard S; Colle I; Lemmers A; Devière J; Le Moine O
    J Hepatol; 2010 Dec; 53(6):1117-22. PubMed ID: 20801542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
    Nguyen-Khac E; Thevenot T; Piquet MA; Benferhat S; Goria O; Chatelain D; Tramier B; Dewaele F; Ghrib S; Rudler M; Carbonell N; Tossou H; Bental A; Bernard-Chabert B; Dupas JL;
    N Engl J Med; 2011 Nov; 365(19):1781-9. PubMed ID: 22070475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.
    Stewart S; Prince M; Bassendine M; Hudson M; James O; Jones D; Record C; Day CP
    J Hepatol; 2007 Aug; 47(2):277-83. PubMed ID: 17532088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice.
    Dupont B; Dao T; Joubert C; Dupont-Lucas C; Gloro R; Nguyen-Khac E; Beaujard E; Mathurin P; Vastel E; Musikas M; Ollivier I; Piquet MA
    Aliment Pharmacol Ther; 2012 May; 35(10):1166-74. PubMed ID: 22452620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.
    Mathurin P; Louvet A; Duhamel A; Nahon P; Carbonell N; Boursier J; Anty R; Diaz E; Thabut D; Moirand R; Lebrec D; Moreno C; Talbodec N; Paupard T; Naveau S; Silvain C; Pageaux GP; Sobesky R; Canva-Delcambre V; Dharancy S; Salleron J; Dao T
    JAMA; 2013 Sep; 310(10):1033-41. PubMed ID: 24026598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.
    Bonkovsky HL; Fiellin DA; Smith GS; Slaker DP; Simon D; Galambos JT
    Am J Gastroenterol; 1991 Sep; 86(9):1200-8. PubMed ID: 1909085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial.
    Cabré E; Rodríguez-Iglesias P; Caballería J; Quer JC; Sánchez-Lombraña JL; Parés A; Papo M; Planas R; Gassull MA
    Hepatology; 2000 Jul; 32(1):36-42. PubMed ID: 10869286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON).
    Komisarof JA; Gilkey GM; Peters DM; Koudelka CW; Meyer MM; Smith SM
    Crit Care Med; 2007 Feb; 35(2):435-41. PubMed ID: 17205018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation.
    Hilmi IA; Peng Z; Planinsic RM; Damian D; Dai F; Tyurina YY; Kagan VE; Kellum JA
    Nephrol Dial Transplant; 2010 Jul; 25(7):2328-33. PubMed ID: 20179007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
    Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G
    Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis.
    Singh V; Keisham A; Bhalla A; Sharma N; Agarwal R; Sharma R; Singh A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1650-1656.e2. PubMed ID: 29391265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition.
    Bonkovsky HL; Singh RH; Jafri IH; Fiellin DA; Smith GS; Simon D; Cotsonis GA; Slaker DP
    Am J Gastroenterol; 1991 Sep; 86(9):1209-18. PubMed ID: 1909086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of alcoholic hepatitis.
    Mathurin P; Lucey MR
    J Hepatol; 2012; 56 Suppl 1():S39-45. PubMed ID: 22300464
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
    Seyon RA; Jensen LA; Ferguson IA; Williams RG
    Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial.
    Macedo E; Abdulkader R; Castro I; Sobrinho AC; Yu L; Vieira JM
    Nephrol Dial Transplant; 2006 Jul; 21(7):1863-9. PubMed ID: 16522657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
    Sharma P; Kumar A; Sharma BC; Sarin SK
    J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.
    Moreno C; Deltenre P; Senterre C; Louvet A; Gustot T; Bastens B; Hittelet A; Piquet MA; Laleman W; Orlent H; Lasser L; Sersté T; Starkel P; De Koninck X; Negrin Dastis S; Delwaide J; Colle I; de Galocsy C; Francque S; Langlet P; Putzeys V; Reynaert H; Degré D; Trépo E
    Gastroenterology; 2016 Apr; 150(4):903-10.e8. PubMed ID: 26764182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic evaluation and management of alcoholic hepatitis.
    Rana R; Wang SL; Li J; Xia L; Song MY; Yang CQ
    Minerva Med; 2017 Dec; 108(6):554-567. PubMed ID: 28602070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early liver transplantation for severe alcoholic hepatitis.
    Mathurin P; Moreno C; Samuel D; Dumortier J; Salleron J; Durand F; Castel H; Duhamel A; Pageaux GP; Leroy V; Dharancy S; Louvet A; Boleslawski E; Lucidi V; Gustot T; Francoz C; Letoublon C; Castaing D; Belghiti J; Donckier V; Pruvot FR; Duclos-Vallée JC
    N Engl J Med; 2011 Nov; 365(19):1790-800. PubMed ID: 22070476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.